Online Only Articles

Outcomes after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia harboring t(7;11)(p15;p15)

Division of Hematology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan;Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Tokyo, Japan
Division of Hematology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
Department of Hematology, Kanagawa Cancer Center, Yokohama, Tokyo, Japan
Department of Hematology, Jyoban Hospital, Tokiwakai, Fukushima, Tokyo, Japan
Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Tokyo, Japan
Department of Stem Cell Transplantation, Niigata University Hospital, Tokyo, Japan
Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo, Japan
Division of Hematology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan
Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
Department of Hematology, Kanagawa Cancer Center, Yokohama, Tokyo, Japan
Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan
Department of Hematology, Sapporo Hokuyu Hospital, University of Tokyo, Japan
Department of Hematology, Fukushima Medical University Hospital, University of Tokyo, Japan
Division of Molecular Therapy, The Advanced Clinical Research Center, The Institute of Medical Science, University of Tokyo, Japan
Department of Hematology and Oncology, Nagoya Daini Red Cross Hospital, Kurume University Hospital, Japan
Department of Hematology, Hyogo Cancer Center, Kurume University Hospital, Japan
Division of Hematology and Oncology, Department of Medicine, Kurume University Hospital, Japan
Department of Hematology, National Hospital Organization Kumamoto Medical Center, Hiroshima University, Japan
Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Japan
Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya University Graduate School of Medicine, Japan;Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Japan
Vol. 103 No. 2 (2018): February, 2018 https://doi.org/10.3324/haematol.2017.179804